KRAS and non-small cell lung carcinoma: Recently, clustered regularly interspaced short palindromic repeats (CRISPR) and kinome-wide high-content short interfering RNA (siRNA) screens have identified ERK5 as a critical prognostic factor for EMT and metastases in KRAS mutant non-small cell lung cancer (NSCLC) and breast cancer, respectively [55].